Coverage of exome sequence testing.

Checkout our iOS App for a better way to browser and research.



  • (1) As used in this section, "exome sequence testing" means a genomic technique for sequencing the genome of an individual for diagnostic purposes.
  • (2) The Medicaid program shall reimburse for exome sequence testing:
    • (a) for an enrollee who:
      • (i) is younger than 21 years of age; and
      • (ii) who remains undiagnosed after exhausting all other appropriate diagnostic-related tests;
    • (b) performed by a nationally recognized provider with significant experience in exome sequence testing;
    • (c) that is medically necessary; and
    • (d) at a rate set by the Medicaid program.




Download our app to see the most-to-date content.